罕见病例:广泛转移的孤立性纤维性肿瘤在[68Ga]Ga-DOTATATE PET/CT上的表现
本文报告一例66岁男性颅内占位初诊为脑膜瘤,术后病理为高危(3级)孤立性纤维性肿瘤(SFT),影像发现左大脑半球、双肺、左肾、C4椎体及头皮多发转移灶均呈放射性摄取增高。结论指出SFT与脑膜瘤影像易混淆,Ga-68 DOTA PET/CT有鉴别价值,但脑膜瘤也可高摄取DOTA、转移灶也可DOTA阳性,需结合影像、临床与病理综合诊断。
要点
- SFT与脑膜瘤影像易混淆,但SFT无钙化或邻近骨增生肥厚。
- Ga-68 DOTA PET/CT有助于鉴别SFT与脑膜瘤,但不能单独确诊。
- 广泛转移且生长抑素受体高表达时,可考虑放射性标记生长抑素类似物治疗。
核心结论
- SFT与脑膜瘤影像表现相似,但二者鉴别至关重要,因SFT罕见、侵袭性强且可能发生颅外转移。
- Ga-68 DOTA PET/CT对鉴别两类肿瘤有重要贡献,但脑膜瘤也可高摄取DOTA,转移灶虽罕见也可DOTA阳性,确诊需综合影像、临床与病理。
- 本病例生长抑素受体高表达,在广泛转移且治疗选择有限时,提示放射性标记生长抑素类似物可能成为潜在治疗选择。
研究设计与样本
- 本文为单例病例报告,报告一例66岁男性颅内占位初诊为脑膜瘤、术后病理为高危(3级)SFT并伴多发颅外转移的诊治经过。
主要发现
- 患者因占位出现压迫症状,行左大脑半球占位手术,病理按WHO分类为高危(3级)SFT,增殖活性高。
- 免疫组化:Bcl-2-124阳性,CD34局灶淡染阳性,CD99膜阳性,Ki67(MIB1)14%,PHH3每10个高倍视野10个细胞阳性,STAT6弥漫核阳性。
- 每10个高倍视野见10个核分裂象。
- 影像显示除颅内病灶外尚有颅外转移,颅内与颅外病灶均呈放射性摄取增高。
临床怎么用
- 对影像疑似脑膜瘤的颅内占位,应警惕SFT可能,注意有无钙化或邻近骨增生肥厚等鉴别线索。
- Ga-68 DOTA PET/CT可用于SFT与脑膜瘤的鉴别评估,但需结合临床与病理,不能仅凭DOTA摄取确诊。
- 对广泛转移且生长抑素受体高表达的SFT,可评估放射性标记生长抑素类似物治疗的可能性。
局限性
- 本文为单例病例报告,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Intracranial solitary fibrous tumor (SFT) are rare pericyte neoplasms arising from the meninges. They resemble meningiomas due to their location and are hyperdense on CT. Therefore, they may be a source of pitfalls. However, unlike meningiomas, there is no calcification or hyperostosis of the adjacent bone. We report a rare case of metastatic SFT presenting with masses in the left cerebral hemisphere, both lungs, left kidney, C4 vertebra, and scalp with intense radiotracer uptake. Case presentation A 66-year-old male patient was referred to our center with intracranial masses initially diagnosed as meningiomas. The patient, who developed compression symptoms, underwent surgery for masses in the left cerebral hemisphere. According to WHO classification [1], the pathology revealed as high-risk (grade 3) SFT with high proliferative activity. Immunohistochemical findings: Bcl-2-124 (positive), CD34 (focal pale positive), CD99 (membranous positive), Ki67 (MIB1): %14, PHH3 (positive in 10 cells in per 10 high-power fields), STAT 6 (diffuse nuclear positive). And 10 mitoses were seen in per 10 high-power fields. Imaging results revealed extracranial metastases in addition to intracranial masses, both demonstrating intense radiotracer uptake. Conclusions Although SFTs can be confused with meningiomas based on imaging findings, distinguishing between the two is crucial due to the rarity, aggressive behavior, and potential for extracranial metastasis associated with SFTs. Ga-68 DOTA PET/CT offers significant contributions to the differential diagnosis of these two tumor types. However, it is known in the literature that meningiomas can also exhibit a high rate of DOTA uptake, and, although rare, extracranial metastases can exhibit DOTA positivity. Therefore, a holistic approach to evaluating radiologic, clinical, and histopathologic findings is necessary for definitive diagnosis, rather than relying solely on Ga-68 DOTA PET/CT findings. Furthermore, as seen in this rare case with limited therapeutic options, the high expression of somatostatin receptor raises the possibility of radiolabeled somatostatin analogs as a potential treatment option in the context of widespread metastatic disease.
引用
- Karasah Erkek B, Sariyildiz Gumusgoz H, Sanli O, et al. A rare case: solitary fibrous tumor with widespread metastasis on [68Ga]Ga-DOTATATE PET/CT. Eur J Nucl Med Mol Imaging. 2025. PMID: 41117981. doi:10.1007/s00259-025-07593-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。